Cited by 15HIV Research and TreatmentT-cell and Retrovirus StudiesGenomics and Chromatin Dynamics

The DOI matches its Crossref record.

Deletion Analysis of Both the Long Terminal Repeat and the Internal Promoters of the Human Foamy Virus

Abstract

Deletion analyses of the long terminal repeat (LTR) and internal promoters (IP) of human foamy virus (HFV) showed that a negative acting element resides in the U5 region of the 5' LTR reducing reporter gene expression tenfold. The basal activity of the IP was higher than that obtained with LTR promoter constructs and strongly elevated in permissive BHK-21 cells whereas semi-permissive COS-7 cells showed low basal activity. Since the basal activity of the IP is critical for initiating HFV gene expression by providing Bel 1 transactivator early after infection, the basal activity of the IP may be the crucial factor that contributes to whether cells are permissive for HFV infection or not. Deletion mutagenesis allowed to define the minimal IP region. A region strongly transactivated by Bel 1 extends from -136 to +58 relative to the cap site of the IP. The major Bel 1 response element of the IP required for transactivation is located upstream of the cap site between -136 and -88 relative to the internal cap site. A DNA fragment reported to be protected by recombinant Bel 1 was deleted with marginal reduction of Bel 1 transactivation. HFV gene expression directed by the IP and LTR promoters is thus multiply regulated by positive and negative acting response elements in cis and their binding partners in trans.

Overview

Integrity signals

Registry

Crossref · 10.1023/a:1007994527345

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In spumaviruses, transcription from the LTR promoter depends on Tas expressed from the IP; use of the IP allows enough Tas to accumulate, facilitating efficient binding to the LTR promoter rather than to the IP, enabling efficient transcription of viral transcripts that express structural and enzymatic proteins.

    “In spumaviruses, since transcription from the LTR promoter depends on Tas (trans-activator of spumavirus), which is expressed from the IP, use of the IP allows enough Tas to accumulate, facilitating its efficient binding to the LTR promoter rather than to the IP. This enables efficient transcription of viral transcripts that express structural and enzymatic proteins (Yang et al. 1997, Kang et al.”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 33

  1. Achong B.C., Mansell P.W., Epstein M.A., and Clifford P., J Natl Cancer Inst 46, 299–307, 1971.
  2. Löchelt M. and Flügel R.M., in Levy J.A. (ed.), The Retroviridae, Plenum Press. Vol 4, pp. 239–292, 1995. · DOI
  3. Muranyi W. and Flügel R.M., J Virol 65, 727–735, 1991. · DOI
  4. Löchelt M., Flügel R.M., and Aboud M., J Virol 68, 638–645, 1994. · DOI
  5. Yu. S.F., Baldwin D.N., Gwynn S.R., Yendapalli S., and Linial M.L., Science 271, 1579–1582, 1996. · DOI
  6. Bodem J., Löchelt M., Winkler I., Flower R.P., Delius H. and Flügel R.M., J Virol 70, 9024–9027, 1996. · DOI
  7. Löchelt M., Muranyi W., and Flügel, R.M., Proc Natl Acad Sci USA 90, 7317–7321, 1993. · DOI · Paper page
  8. Keller A., Partin K.M., Löchelt M., Bannert H., Flügel R.M. and Cullen B.R., J Virol 65, 2589–2594, 1991. · DOI
  9. Rethwilm A., Erlwein, O., Baunach, G., Maurer, B., and ter Meulen, V., Proc Natl Acad Sci USA 88, 941–945, 1991. · DOI
  10. He F., Sun J.D., Garrett E.D., and Cullen, B.R., J Virol 67, 1896–1904, 1993. · DOI
  11. Lee C.W., Chang J., Lee K.J., Kim S., and Sung Y.C., J Virol 68, 2708–2719, 1994. · DOI
  12. Venkatesh L.L. and Chinnadurai G., J Virol 67, 3868–3876, 1993. · DOI
  13. Ventatesh L.K., Yang C., Theodorakis P.A., and Chinnadurai G., J Virol 67, 161–169, 1993. · DOI
  14. Chang J., Lee K.J., Jang K.L., Lee E.K., Baek G.H., and Sung Y.C., J Virol 69, 801–808, 1995. · DOI
  15. Mergia A., Renshaw-Gegg L.W., Stout M.W., Renne R., and Herchenröder O., J Virol 67, 4598–4604, 1993. · DOI
  16. Löchelt M., Zentgraf H., and Flügel R.M., Virology 184, 43–54, 1991. · DOI
  17. Yu S.F. and Linial M.L., J Virol 67, 6618–6624, 1993. · DOI
  18. Baunach G., Maurer B., Hahn H., Kranz M., and Rethwilm, A., J Virol 67, 5411–5418, 1993. · DOI · Paper page
  19. Löchelt M., Yu S.F., Linial M.L., and Flügel R.M., Virology 206, 601–610, 1995. · DOI
  20. Keller A., Garrrett E.D., and Cullen B.R., J Virol 66, 3946–3949, 1992. · DOI
  21. Lee A.H., Lee K.J., Kim S., and Sung Y.C., J Virol 66, 3236–3240, 1992. · DOI
  22. Lee K.J., Lee A.H., and Sung Y.C., J Virol 67, 2317–2326, 1993. · DOI
  23. Mergia A., Pratt-Lowe E., Shaw K.E.S., Renshaw L.W., and Luciw P.A., J Virol 66, 251–257, 1992. · DOI
  24. Erlwein O. and Rethwilm A., Virology 196, 256–268, 1993. · DOI
  25. Campbell M., Renshaw-Gegg L., Renne R., and Luciw P.A., J Virol 68, 4811–4820, 1994. · DOI · Paper page
  26. Zhou J.X. and Luciw P.A., Proc Natl Acad Sci USA 93, 326–330, 1996. · DOI
  27. He F., Blair W.S., Fukushima J., and Cullen B.R., J Virol 70, 3902–3908, 1996. · DOI
  28. Boshart M., Klüppel M., Schmidt A., Schütz G., and Luckow B., Gene 110, 129–130, 1992. · DOI
  29. Döffinger R., Pawlita M., and Sczakiel G., Nucl Acids Res 16, 11840, 1988. · DOI
  30. Gorman C.M., Moffat L.F., and Howard B.H., Mol Cell Biol 2, 1044–1051, 1982.
  31. Maniatis T., Sambrook J., and Fritsch E.F., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor University Press, Cold Spring Harbor, NY., 1989.
  32. de Wet J.R., Wood K.V., DuLuca M., Helsinki D.R., and Subramani S., Mol Cell Biol 7, 725–737, 1987.
  33. Hoppe-Seyler F., Butz K., Rittmüller C., and von Knebel Doeberitz M., Nucl Acids Res 19, 5080, 1991. · DOI

Cited by

Sorted by citations

Metadata

Authors
Yang, P., Zemba, M., Aboud, M., Flügel, R. M., & Löchelt, M.
Affiliations
  • German Cancer Research Center (DE)
  • Ben-Gurion University of the Negev (IL)
Venue
Virus Genes
Published
1997-07
Volume
15
Issue
1
Pages
17-23
ISSN
  • 0920-8569 (ISSN-L)
  • 1572-994X
OpenAlex
W2260381594
Cited by
15
References
0
Citations by year
2025: 1 · 2018: 1 · 2013: 1 · 2012: 2
FWCI
0.40
Type
journal article
Language
en
Open access
closed
Locations
  • Virus Genes (publishedVersion)
  • PubMed (publishedVersion)
Funders
Deutscher Akademischer Austauschdienst
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
human foamy virus, long terminal repeat, internal promoter, U5 region, permissive cells, viral gene expression regulation
MeSH terms
Animals, Cells, Cultured, Cricetinae, Humans, Promoter Regions, Genetic, Regulatory Sequences, Nucleic Acid, Repetitive Sequences, Nucleic Acid, Viral Proteins, Spumavirus, Genome, Viral, Gene Deletion, COS Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review